The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention is a research paper published in The International Journal of Neuropsychopharmacology (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 DA57928
National Institutes of Health
Grant: K01 AA28050
National Institutes of Health
Grant: R01 AA27486
National Institutes of Health
Grant: R18 HS29774
the Brain & Behavior Research Foundation
Grant: 31329
AHRQ HHS
Grant: R18 HS029774
National Institutes of Health
Grant: 5R18HS029774-03
Connecting Primary Care to Substance Use Disorder Treatment Using a Telehealth Collaborative Care Platform
National Institutes of Health
Grant: 1R01AA027486-01
Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics
National Institutes of Health
Grant: 5K01AA028050-05
Acamprosate pharmacogenomics: iPSC based model of alcohol use disorder
National Institutes of Health
Grant: 5R01DA057928-03
Single cell multi-omics of iPSC-derived brain organoids from patients with opioid use disorder: synthetic opioids as molecular probes
Terrance and Bette Noble Foundation
Mayo Clinic Center for Individualized Medicine
Mayo Clinic Research Pipeline K2R Program
Mayo Clinic Research Pipeline K2R Program
Terrance and Bette Noble Foundation
Mayo Clinic Center for Individualized Medicine
FWCI
6.56
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals